Fluoxetine not effective for COVID-19 patients

Fluoxetine not effective for COVID-19 patients

Source: News-Medical.Net

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

Evidence shows weak antiviral activity and no improvement in symptom outcomes.
Study: Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV). Image Credit: luchschenF/S… [4796 chars]

Read more